2021
DOI: 10.1039/d1ra01809d
|View full text |Cite
|
Sign up to set email alerts
|

In silico identification of potential SARS COV-2 2′-O-methyltransferase inhibitor: fragment-based screening approach and MM-PBSA calculations

Abstract: The identification of AP-20 as a potential SARS COV-2 2′-O-methyltransferase inhibitor: fragment-based screening approach and MM-PBSA calculations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 53 publications
0
12
0
Order By: Relevance
“…The free EGFR enzyme and the retrieved docking coordinates of the same enzyme bound Erlotinib, 9k and 9g were used as input structures for the molecular dynamics. The typical work scheme of Gromacs simulation was applied to conduct the four MDS 41 45 (Supplementary Materials).…”
Section: Methodsmentioning
confidence: 99%
“…The free EGFR enzyme and the retrieved docking coordinates of the same enzyme bound Erlotinib, 9k and 9g were used as input structures for the molecular dynamics. The typical work scheme of Gromacs simulation was applied to conduct the four MDS 41 45 (Supplementary Materials).…”
Section: Methodsmentioning
confidence: 99%
“…Later on, complex topology was generated through joining both ligand and enzymes. As already published in the literature, the typical scheme for enzyme-ligand simulations by GROMACS was applied, starting with system solvation using a single point charge (SPC) water model and ending with neutralization by adding the suitable number of counter ions (El Hassab et al 2020, 2021, 2022a, 2022b.…”
Section: Molecular Dynamicsmentioning
confidence: 99%
“…In the repurposing against nsp16 involving 4200 drugs or compounds, the best one predicted from MM-PBSA was Carba-nicotinamide-adenine-dinucleotide . The potency of hundreds of bioactive compounds to methyltransferase was also studied via docking and MM/PBSA calculations. , Moreover, El Hassab et al designed a new methyltransferase inhibitor AP-20 based on fragments and calculated the binding affinity using MM/PBSA. Since the MMLFA-1/SARS-CoV-2 Orf7a complex contributes to SARS-CoV-2 infectivity and pathogenicity, Ongaro et al used MM/GBSA calculations to study the interactions inside the MMLFA-1/SARS-CoV-2 Orf7a complex.…”
Section: Methods and Approachesmentioning
confidence: 99%
“…In the work of searching COVID-19 therapeutics, most pharmacophore models focused on Mpro. ,,,, Pharmacophore models were used to screen inhibitor compounds to SARS-CoV-2 from FDA-approved drugs, , DrugBank, or HIV inhibitors. , A fragment-based pharmacophore model was built from 22 noncovalent fragments cocrystallized with Mpro . More pharmacophore models were created for Mpro, PLpro, and nsp16 …”
Section: Methods and Approachesmentioning
confidence: 99%